Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention

BACKGROUND AND AIMS Determining the gene that plays a key role in brain-gut interactions is a crucial step for clarifying the pathophysiology of irritable bowel syndrome (IBS). We previously reported that the 5-hydroxytryptamine transporter gene-linked polymorphic region (5-HTTLPR) is related to anxiety in subjects with IBS. The amygdala is more activated during fearful face recognition in individuals with the s allele of 5-HTTLPR. Here, we tested our hypothesis that 5-HTTLPR differentially activates brain regions with colorectal distention in humans. METHODS We enrolled 28 subjects without any organic disease. The study was approved by the Ethics Committee and all subjects gave written informed consent. DNA was extracted from the peripheral blood. The genotype of 5-HTTLPR was determined using polymerase chain reaction. Age, sex, diagnosis-matched individuals with the s/s genotype (n=14) and individuals with the l allele (genotypes l/s, l/l, l/extra-l, n=14) were compared. A barostat bag was inserted to the colorectum and was intermittently inflated with no (0 mm Hg), mild (20 mm Hg), or intense (40 mm Hg) stimulation on a random order. Radioactive H2[(15-)O] saline was injected at bag inflation and then positron emission tomography was performed. Changes in rCBF were analyzed using statistical parametric mapping. RESULTS Individuals with the s/s genotype showed a significantly larger increase in rCBF by colorectal distention from 0 mm Hg to 40 mm Hg than individuals with the l allele. The significantly more activated brain regions in individuals with the s/s genotype were the left anterior cingulate cortex and right parahippocampal gyrus (p<0.0001). The increase in rCBF by colorectal distention of 20 mm Hg compared with 0 mm Hg was significantly larger in the left orbitofrontal cortex of individuals with the s/s genotype than that of individuals with the l allele (p<0.0001). CONCLUSION These data suggest that individuals with a weak function of serotonin transporter respond to gut signals more in emotion-regulating brain regions. Functional gene polymorphism may partially predict the individual effect of a selective serotonin reuptake inhibitor on visceral pain.

[1]  M. Alexander,et al.  Principles of Neural Science , 1981 .

[2]  David Thompson,et al.  Functional bowel disorders , 2005, Digestive Diseases and Sciences.

[3]  R. Kessler,et al.  Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. , 2000, Gastroenterology.

[4]  Tomoyuki Yambe,et al.  Brain Activation Associated With Changes in Heart Rate, Heart Rate Variability, and Plasma Catecholamines During Rectal Distention , 2009, Psychosomatic medicine.

[5]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[6]  E. Rolls,et al.  Abstract reward and punishment representations in the human orbitofrontal cortex , 2001, Nature Neuroscience.

[7]  Kazuhiko Yanai,et al.  Correlation between alexithymia and hypersensitivity to visceral stimulation in human , 2007, PAIN.

[8]  Henry Kranzler,et al.  Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects , 1997, Human Genetics.

[9]  H Orihara,et al.  Performance evaluation of a large axial field-of-view PET scanner: SET-2400W , 1997, Annals of nuclear medicine.

[10]  L. Siever,et al.  Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. , 1998, The American journal of psychiatry.

[11]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[12]  David Goldman,et al.  Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. , 2006, American journal of human genetics.

[13]  E. Rolls,et al.  The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology , 2004, Progress in Neurobiology.

[14]  Miklós Palkovits,et al.  Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims , 1999, Biological Psychiatry.

[15]  H. Damasio,et al.  The Iowa Gambling Task and the somatic marker hypothesis: some questions and answers , 2005, Trends in Cognitive Sciences.

[16]  A. Craig,et al.  REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY Neuroimaging of the Brain-Gut Axis: From Basic Understanding to Treatment of Functional GI Disorders , 2006 .

[17]  K. Ressler,et al.  Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic , 2007, Nature Neuroscience.

[18]  R. Rezzani,et al.  Expression of Fos immunoreactivity in the rat supraspinal regions following noxious visceral stimulation , 1998, Brain Research Bulletin.

[19]  M. Gioia,et al.  Immunocytochemical localization of extracellular signal-regulated kinases 1 and 2 phosphorylated neurons in the brainstem of rat following visceral noxious stimulation , 2003, Neuroscience Letters.

[20]  K. Gadde,et al.  Central Nervous System Serotonin Function and Cardiovascular Responses to Stress , 2001, Psychosomatic medicine.

[21]  S. Fukudo,et al.  Brain activity during distention of the descending colon in humans , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[22]  A. Craig.  How do you feel? Interoception: the sense of the physiological condition of the body , 2002, Nature Reviews Neuroscience.

[23]  M. First,et al.  Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research version (SCID-I RV) , 2002 .

[24]  Richard D. Lane,et al.  Neural correlates of conscious emotional experience. , 2000 .

[25]  A. Meyer-Lindenberg,et al.  5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression , 2005, Nature Neuroscience.

[26]  A. Colino,et al.  Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin , 1987, Nature.

[27]  Martin P Paulus,et al.  Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain. , 2008, Archives of general psychiatry.

[28]  L. Nadel,et al.  Cognitive neuroscience of emotion , 2000 .

[29]  R Todd Constable,et al.  Role of Variation in the Serotonin Transporter Protein Gene (SLC6A4) in Trait Disturbances in the Ventral Anterior Cingulate in Bipolar Disorder , 2009, Neuropsychopharmacology.

[31]  Yasuto Itoyama,et al.  Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. , 2006, Journal of psychosomatic research.

[32]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[33]  Gerd Wagner,et al.  Fronto-cingulate effective connectivity in major depression: A study with fMRI and dynamic causal modeling , 2008, NeuroImage.

[34]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[35]  Jeremy Veenstra-Vander Weele,et al.  Serotonin Transporter and Seasonal Variation in Blood Serotonin in Families with Obsessive-Compulsive Disorder , 1998, Neuropsychopharmacology.

[36]  Peggy Mason,et al.  Role for raphe magnus neuronal responses in the behavioral reactions to colorectal distension. , 2004, Journal of neurophysiology.

[37]  Karl J. Friston,et al.  Spatial registration and normalization of images , 1995 .

[38]  A. Craig,et al.  How do you feel — now? The anterior insula and human awareness , 2009, Nature Reviews Neuroscience.

[39]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[40]  A Frazer,et al.  Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies. , 2001, The Journal of clinical psychiatry.